+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Single Nucleotide Polymorphism (SNP) Genotyping Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5896190
The single nucleotide polymorphism (snp) genotyping market size has grown exponentially in recent years. It will grow from $8.48 billion in 2023 to $10.24 billion in 2024 at a compound annual growth rate (CAGR) of 20.7%. The expansion during the historical period can be attributed to increasing research in genomics, a rise in genetic disorders, growth in personalized medicine, the expanding pharmaceutical industry, and rising demand for molecular diagnostics.

The single nucleotide polymorphism (snp) genotyping market size is expected to see rapid growth in the next few years. It will grow to $20.6 billion in 2028 at a compound annual growth rate (CAGR) of 19.1%. The anticipated growth in the forecast period can be attributed to growing applications in disease research, a rise in demand for precision medicine, expanding biobanking initiatives, a surge in genetic testing, and rising adoption in agriculture for crop improvement. Key trends expected in the forecast period include the increasing use of next-generation sequencing (NGS), rising demand for SNP genotyping in pharmacogenomics, the emergence of direct-to-consumer genetic testing, and a focus on automation and high-throughput genotyping platforms.

The growth of the single nucleotide polymorphism (SNP) genotyping market is anticipated to be driven by the increasing burden of chronic conditions. Chronic conditions, defined as ailments lasting a year or more and requiring ongoing medical care, significantly impact daily activities. Single Nucleotide Polymorphism (SNP) genotyping plays a crucial role in identifying genetic predispositions, contributing to the rise of personalized medicine amidst the growing prevalence of chronic diseases. As indicated by the National Center for Biotechnology Information (NCBI) in January 2023, the global number of individuals with chronic diseases is projected to reach 142.66 million by 2050, up from 71.522 million in 2020. This escalation in the burden of chronic conditions is a key factor propelling the growth of the single nucleotide polymorphism (SNP) genotyping systems market.

The increasing allocation of funds for genomic research is poised to further boost the growth of the single nucleotide polymorphism (SNP) genotyping market. Funds for genomic research encompass financial resources dedicated to supporting research activities in genomics, crucial for advancing SNP studies. Organizations such as the National Human Genome Research Institute received $604 million in 2020, $614 million in 2021, and $616 million in 2022, with a proposed budget of $629 million for 2023. Additionally, the Biden administration allocated $1.7 billion in April 2021 to enhance SARS-CoV-2 variant detection, monitoring, and mitigation, emphasizing the establishment of genomic sequencing infrastructure. This rise in funds for genomic research is a significant driver of the single nucleotide polymorphism (SNP) genotyping market.

A prominent trend in the single nucleotide polymorphism (SNP) genotyping market is the adoption of technological solutions. Major companies in this market are introducing advanced solutions to maintain their market position. For instance, in May 2022, Neogen Corporation and Gencove launched InfiniSEEK, the first complete genome and genotyping tool for cattle breeders. InfiniSEEK's validation demonstrates high concordance with deep whole-genome sequencing, providing clinical-grade accuracy in specific areas of interest. This technological advancement underscores the commitment of companies to bring innovative solutions to the single nucleotide polymorphism (SNP) genotyping market.

Companies in the single nucleotide polymorphism (SNP) genotyping market are also focusing on developing biomarkers for coronary heart disease detection, enhancing market profitability. Single nucleotide polymorphism (SNP) biomarkers associated with coronary heart disease (CHD) detection are genetic variations linked to an increased risk of CHD. For instance, Cardio Diagnostics launched PrecisionCHD in February 2023, an AI-driven blood test utilizing epigenetic and genetic biomarkers to detect CHD. This non-invasive test eliminates the need for traditional methods, providing objectivity through biomarkers rather than self-reported patient data.

In July 2021, DiaSorin S.p.A. acquired Luminex Corporation for approximately $1.8 billion. This strategic move aims to broaden the applications of Luminex across the Life Science sector, strengthening collaboration with the biopharmaceutical industry and enhancing the availability of clinical multiplexing assays. Luminex Corporation, a US-based biotechnology company, specializes in single nucleotide polymorphism (SNP) genotyping technology.

Major companies operating in the single nucleotide polymorphism (snp) genotyping market report are Thermo Fisher Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc.

North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (snp) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single nucleotide polymorphism (snp) genotyping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary products of single nucleotide polymorphism (SNP) genotyping include consumables, instruments, and services. Consumables refer to items that people and businesses regularly consume or use up, requiring replacement, such as food and home supplies. Various technologies are employed in SNP genotyping, including TaqMan SNP genotyping, Mass Array SNP genotyping, SNP gene chip arrays, and others. These technologies find applications in diverse fields such as animal genetics, plant improvement, diagnostic research, pharmaceuticals and pharmacogenomics, agricultural biotechnology, and more.

The single nucleotide polymorphism (SNP) genotyping market research report is one of a series of new reports that provides single nucleotide polymorphism (SNP) genotyping market statistics, including the single nucleotide polymorphism (SNP) genotyping industry's global market size, regional shares, competitors with a single nucleotide polymorphism (SNP) genotyping market share, detailed single nucleotide polymorphism (SNP) genotyping market segments, market trends and opportunities, and any further data you may need to thrive in the single nucleotide polymorphism (SNP) genotyping industry. This single nucleotide polymorphism (SNP) genotyping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The single nucleotide polymorphism (SNP) genotyping market includes revenues earned by providing sample collection, DNA extraction, high-resolution melting analysis, and related next-generation sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The single nucleotide polymorphism (SNP) genotyping market consists of sales of mass spectrometry-based SNP genotyping and allele-specific PCR. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Single Nucleotide Polymorphism (SNP) Genotyping Market Characteristics3. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends and Strategies
4. Single Nucleotide Polymorphism (SNP) Genotyping Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth
5.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Single Nucleotide Polymorphism (SNP) Genotyping Market Segmentation
6.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Instruments
  • Services
6.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • TaqMan SNP Genotyping
  • Mass Array SNP Genotyping
  • SNP Gene Chip Arrays
  • Other Technologies
6.3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Animal Genetics
  • Plant Improvement
  • Diagnostic Research
  • Pharmaceuticals and Pharmacogenomics
  • Agricultural Biotechnology
  • Other Applications
7. Single Nucleotide Polymorphism (SNP) Genotyping Market Regional and Country Analysis
7.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market
8.1. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Single Nucleotide Polymorphism (SNP) Genotyping Market
9.1. China Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
9.2. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Single Nucleotide Polymorphism (SNP) Genotyping Market
10.1. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market
11.1. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
11.2. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market
12.1. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market
13.1. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market
14.1. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
14.2. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market
15.1. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
15.2. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Single Nucleotide Polymorphism (SNP) Genotyping Market
16.1. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market
17.1. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Single Nucleotide Polymorphism (SNP) Genotyping Market
18.1. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market
19.1. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market
20.1. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market
21.1. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
21.2. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market
22.1. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Single Nucleotide Polymorphism (SNP) Genotyping Market
23.1. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
23.2. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Single Nucleotide Polymorphism (SNP) Genotyping Market
24.1. USA Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
24.2. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market
25.1. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
25.2. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Single Nucleotide Polymorphism (SNP) Genotyping Market
26.1. South America Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
26.2. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market
27.1. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market
28.1. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
28.2. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market
29.1. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
29.2. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Landscape and Company Profiles
30.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Landscape
30.2. Single Nucleotide Polymorphism (SNP) Genotyping Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Danaher Corporation
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Roche Diagnostics Corporation
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. GE HealthCare Technologies Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Eurofins Genomics LLC
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Single Nucleotide Polymorphism (SNP) Genotyping Market Other Major and Innovative Companies
31.1. Beckman Coulter Inc.
31.2. Bio-Rad Laboratories Inc.
31.3. Qiagen N.V.
31.4. Sigma-Aldrich Corporation
31.5. Agilent Technologies Inc.
31.6. PerkinElmer Inc.
31.7. Illumina Inc.
31.8. Promega Corporation
31.9. GenScript Biotech Corporation
31.10. Integrated DNA Technologies Inc.
31.11. LGC Ltd.
31.12. Sequenom Inc.
31.13. Fluidigm Corporation
31.14. Agendia Inc.
31.15. Nugen Technologies Inc.
32. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Benchmarking33. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Dashboard34. Key Mergers and Acquisitions in the Single Nucleotide Polymorphism (SNP) Genotyping Market
35. Single Nucleotide Polymorphism (SNP) Genotyping Market Future Outlook and Potential Analysis
35.1 Single Nucleotide Polymorphism (SNP) Genotyping Market in 2028 - Countries Offering Most New Opportunities
35.2 Single Nucleotide Polymorphism (SNP) Genotyping Market in 2028 - Segments Offering Most New Opportunities
35.3 Single Nucleotide Polymorphism (SNP) Genotyping Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Single Nucleotide Polymorphism (SNP) Genotyping Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single nucleotide polymorphism (snp) genotyping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for single nucleotide polymorphism (snp) genotyping? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Product: Consumables; Instruments; services
2) By Technology: TaqMan SNP Genotyping; Mass Array SNP Genotyping; SNP Gene Chip Arrays; Other Technologies
3) By Application: Animal Genetics; Plant Improvement; Diagnostic Research; Pharmaceuticals and Pharmacogenomics; Agricultural Biotechnology; Other Applications

Key Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Roche Diagnostics Corporation; GE HealthCare Technologies Inc.; Eurofins Genomics LLC

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Roche Diagnostics Corporation
  • GE HealthCare Technologies Inc.
  • Eurofins Genomics LLC
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V.
  • Sigma-Aldrich Corporation
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Illumina Inc.
  • Promega Corporation
  • GenScript Biotech Corporation
  • Integrated DNA Technologies Inc.
  • LGC Ltd.
  • Sequenom Inc.
  • Fluidigm Corporation
  • Agendia Inc.
  • Nugen Technologies Inc.
  • BioChain Institute Inc.
  • Standard BioTools Inc.
  • Oxford Gene Technology
  • Affymetrix Inc.
  • PREMIER Biosoft International Inc.
  • GenoLogics
  • Rubicon Genomics Inc.
  • Xcelris Genomics
  • Douglas Scientific LLC
  • Golden Helix Inc.

Methodology

Loading
LOADING...

Table Information